685 A first-in-human Phase 1/2 clinical trial of SIRPαlow activated macrophages (SIRPant-M) for the treatment of R/R-NHL
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1827764039690747904 |
|---|---|
| author | Koby Kidder Rita N Barcia Stephen Fogelson Candida Fratazzi Nathanael McCurley |
| author_facet | Koby Kidder Rita N Barcia Stephen Fogelson Candida Fratazzi Nathanael McCurley |
| author_sort | Koby Kidder |
| collection | DOAJ |
| first_indexed | 2024-03-11T10:59:07Z |
| format | Article |
| id | doaj.art-55ace57f7dfe4f9dbeeb95728fafee59 |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-03-11T10:59:07Z |
| publishDate | 2023-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-55ace57f7dfe4f9dbeeb95728fafee592023-11-12T13:45:08ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.0685685 A first-in-human Phase 1/2 clinical trial of SIRPαlow activated macrophages (SIRPant-M) for the treatment of R/R-NHLKoby Kidder0Rita N Barcia1Stephen Fogelson2Candida Fratazzi3Nathanael McCurley4Aff266 grid.256304.60000000419367400Georgia State University Atlanta GA USA1SIRPant Immunotherapeutics, Hummelstown, PA, USA2Develotron, LLC, Hillsborough, NH, USA3BBCR, Cambridge, MA, USA1SIRPant Immunotherapeutics, Hummelstown, PA, USA |
| spellingShingle | Koby Kidder Rita N Barcia Stephen Fogelson Candida Fratazzi Nathanael McCurley 685 A first-in-human Phase 1/2 clinical trial of SIRPαlow activated macrophages (SIRPant-M) for the treatment of R/R-NHL Journal for ImmunoTherapy of Cancer |
| title | 685 A first-in-human Phase 1/2 clinical trial of SIRPαlow activated macrophages (SIRPant-M) for the treatment of R/R-NHL |
| title_full | 685 A first-in-human Phase 1/2 clinical trial of SIRPαlow activated macrophages (SIRPant-M) for the treatment of R/R-NHL |
| title_fullStr | 685 A first-in-human Phase 1/2 clinical trial of SIRPαlow activated macrophages (SIRPant-M) for the treatment of R/R-NHL |
| title_full_unstemmed | 685 A first-in-human Phase 1/2 clinical trial of SIRPαlow activated macrophages (SIRPant-M) for the treatment of R/R-NHL |
| title_short | 685 A first-in-human Phase 1/2 clinical trial of SIRPαlow activated macrophages (SIRPant-M) for the treatment of R/R-NHL |
| title_sort | 685 a first in human phase 1 2 clinical trial of sirpαlow activated macrophages sirpant m for the treatment of r r nhl |
| work_keys_str_mv | AT kobykidder 685afirstinhumanphase12clinicaltrialofsirpalowactivatedmacrophagessirpantmforthetreatmentofrrnhl AT ritanbarcia 685afirstinhumanphase12clinicaltrialofsirpalowactivatedmacrophagessirpantmforthetreatmentofrrnhl AT stephenfogelson 685afirstinhumanphase12clinicaltrialofsirpalowactivatedmacrophagessirpantmforthetreatmentofrrnhl AT candidafratazzi 685afirstinhumanphase12clinicaltrialofsirpalowactivatedmacrophagessirpantmforthetreatmentofrrnhl AT nathanaelmccurley 685afirstinhumanphase12clinicaltrialofsirpalowactivatedmacrophagessirpantmforthetreatmentofrrnhl |